Identification, assessment, and therapy of cancers with innate or acquired resistance to ALK inhibitors

Details for Australian Patent Application No. 2011212165 (hide)

Owner Jichi Medical University

Inventors Mano, Hiroyuki; Choi, Young L.; Soda, Manabu

Agent Spruson & Ferguson

Pub. Number AU-A-2011212165

PCT Pub. Number WO2011/095894

Priority 61/337,465 04.02.10 US

Filing date 4 February 2011

Wipo publication date 11 August 2011

International Classifications

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/095894 Priority application(s): WO2011/095894

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011212184-Process for the acetylation of wood elements

2011212153-Combination composition, comprising as active ingredient L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency